Hospira Vincristine Sulphate 5 mg/5 mL Injection vial (preserved)

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

vincristine sulfate, Quantity: 1 mg/mL

متاح من:

Hospira Australia Pty Ltd

INN (الاسم الدولي):

Vincristine sulfate

الشكل الصيدلاني:

Injection, solution

تركيب:

Excipient Ingredients: benzyl alcohol; mannitol; water for injections

طريقة التعاطي:

Intravenous

الوحدات في الحزمة:

5 x 5 mL pack

الفئة:

Medicine Listed (Export Only)

نوع الوصفة الطبية :

(S1) This Schedule is intentionally blank

الخصائص العلاجية:

Vincristine Sulphate Injection is used in the treatment of cancers of the blood (eg. leukaemia or lymphomas), breast, head and neck or lung. It may be used to treat multiple myeloma (a cancer of plasma cells) and it may also be used in the treatment of some cancers in children. It may be used in a blood disorder known as idiopathic thrombocytopenic purpura (ITP) after other treatments have not been successful. Vincristine Sulphate Injection may be given alone or in combination with other anti-cancer medicines.

ملخص المنتج:

Visual Identification: A clear colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

الوضع إذن:

Licence status A

تاريخ الترخيص:

2011-11-02